Zhe Jiang Hai Liang Co., Ltd (002203.SZ) reported earnings for its nine months that Increased, from the same period last year
The company's bottom line came in at RMB1.148 billion, or RMB0.52 per share. This compares with RMB924.66 million, or RMB0.51 per share, last year.
The company's revenue for the period rose 15.1% to RMB74.861 billion from RMB65.018 billion last year.
Zhe Jiang Hai Liang Co., Ltd earnings at a glance (GAAP) :
-Earnings: RMB1.148 Bln. vs. RMB924.66 Mln. last year.-EPS: RMB0.52 vs. RMB0.51 last year.-Revenue: RMB74.861 Bln vs. RMB65.018 Bln last year.
For comments and feedback contact: [email protected]
October 27, 2026 07:42 ET November brings a new lineup of FDA regulatory milestones that could influence biotech stocks. This video highlights five biotech companies to watch ahead of their upcoming FDA decisions, spanning potential treatments for sickle cell disease, psychiatric disorders, cardiovascular conditions, and cancer.